sagehq
@llamae3gs
Hey, that's intriguing! Curious about the benefit of utilizing predicted/generated TCRs. It appears quite risky, and you'd still need scRNA-seq or proteomics on the tumor to profile neoantigens.
0 reply
0 recast
0 reaction